Promoting the safe use of intravenous colchicine

American Journal of Health-System Pharmacy

Volumn 61, Issue 23, 2004, Pages

  Tortorici, Michael A ^a   Skledar, Sue ^b   Barnes, Barbara ^a   Wasko, Mary Chester M ^c  

^a UNIVERSITY OF PITTSBURGH   (United States)

^b UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^c UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COLCHICINE; ANTIGOUT AGENT;

BONE MARROW SUPPRESSION; COMORBIDITY; DRUG SAFETY; ELECTROLYTE DISTURBANCE; GASTROINTESTINAL SYMPTOM; GOUT; HUMAN; HYPOVOLEMIA; INFECTION; KIDNEY FUNCTION; MEDICATION ERROR; MORTALITY; PATIENT SELECTION; PHARMACIST; PHARMACY AND THERAPEUTICS COMMITTEE; PRACTICE GUIDELINE; PRIORITY JOURNAL; SHORT SURVEY; ARTICLE; INTRAVENOUS DRUG ADMINISTRATION;

COLCHICINE; GOUT SUPPRESSANTS; HUMANS; INJECTIONS, INTRAVENOUS; PRACTICE GUIDELINES;

EID: 15544386617     PISSN: 10792082     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajhp/61.23.2496     Document Type: Short Survey

References (5)

1. Hawkins DW, Rahn DW. Gout and hyperuricemia. In: Dipiro JT, Talbert RL, Yee GC et al., eds. Pharmacotherapy: a pathophysiologic approach. 5th ed. New York: McGraw-Hill; 2002:1659-64.
2. Maxwell MJ, Muthu P, Pritty PE. Accidental colchicines overdose: a case report and literature review. Emerg Med. 2002; 19: 265-7.
3. Roberts WN, Liang MH, Stern SH. Colchicine in acute gout. Reassessment of risks and benefits. JAMA. 1987; 257:1920-2.
4. Walsh CS, Grissinger M. Medication errors: prevention guidelines. Pharm Pract News. 2002; Nov: 39-41.
5. Milne ST, Meek PD. Fatal colchicine overdose: report of a case and review of the literature. Am J Emerg Med. 1998; 16:603-8.